AXSOME THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$1M
Free Cash Flow↓-136.7% -$41K
$-71K
Investing Cash Flow↓-244.9% -$240K
$-338K
Financing Cash Flow↑+15.0% +$2M
$16M
Capex↑+136.7% +$41K
$71K
Stock-Based Comp↑+3.4% +$744K
$23M
Debt Issued
—
Debt Repaid
$70M
D&A↓-11.6% -$15K
$114K
SBC Allocated Expense↑+3.4% +$744K
$23M